A detailed history of Valley National Advisers Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Valley National Advisers Inc holds 4,318 shares of LLY stock, worth $3.39 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
4,318
Previous 5,901 26.83%
Holding current value
$3.39 Million
Previous $5.34 Million 28.41%
% of portfolio
0.69%
Previous 0.79%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $1.22 Million - $1.52 Million
-1,583 Reduced 26.83%
4,318 $3.83 Million
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $97,713 - $130,726
165 Added 2.88%
5,901 $4.59 Million
Q4 2023

Jan 25, 2024

BUY
$525.19 - $619.13 $176,989 - $208,646
337 Added 6.24%
5,736 $3.34 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $3,042 - $4,195
-7 Reduced 0.13%
5,399 $2.9 Million
Q2 2023

Jul 31, 2023

BUY
$350.74 - $468.98 $10,872 - $14,538
31 Added 0.58%
5,406 $2.54 Million
Q1 2023

Apr 26, 2023

SELL
$310.63 - $364.82 $61,194 - $71,869
-197 Reduced 3.54%
5,375 $2.06 Million
Q4 2022

Jan 12, 2023

SELL
$321.55 - $374.67 $796,157 - $927,682
-2,476 Reduced 30.77%
5,572 $2.01 Million
Q3 2022

Nov 08, 2022

SELL
$296.48 - $337.87 $13,045 - $14,866
-44 Reduced 0.54%
8,048 $2.7 Million
Q2 2022

Jul 15, 2022

SELL
$278.73 - $327.27 $31,775 - $37,308
-114 Reduced 1.39%
8,092 $2.65 Million
Q1 2022

May 06, 2022

BUY
$234.69 - $291.66 $72,988 - $90,706
311 Added 3.94%
8,206 $2.35 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $35,526 - $44,088
-158 Reduced 1.96%
7,895 $2.18 Million
Q3 2021

Nov 10, 2021

SELL
$221.6 - $272.71 $134,732 - $165,807
-608 Reduced 7.02%
8,053 $1.86 Million
Q2 2021

Aug 02, 2021

SELL
$180.55 - $233.54 $8,305 - $10,742
-46 Reduced 0.53%
8,661 $1.99 Million
Q1 2021

May 07, 2021

BUY
$164.32 - $212.72 $200,963 - $260,156
1,223 Added 16.34%
8,707 $1.63 Million
Q4 2020

Feb 11, 2021

SELL
$130.46 - $172.63 $16,698 - $22,096
-128 Reduced 1.68%
7,484 $1.26 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $17,253 - $19,957
-118 Reduced 1.53%
7,612 $1.13 Million
Q2 2020

Aug 10, 2020

SELL
$136.42 - $164.18 $9,276 - $11,164
-68 Reduced 0.87%
7,730 $1.27 Million
Q1 2020

May 13, 2020

BUY
$119.05 - $147.35 $31,072 - $38,458
261 Added 3.46%
7,798 $1.08 Million
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $4,169 - $5,164
-39 Reduced 0.51%
7,537 $991,000
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $6,941 - $7,550
-65 Reduced 0.85%
7,576 $847,000
Q2 2019

Aug 08, 2019

SELL
$110.79 - $129.32 $6,647 - $7,759
-60 Reduced 0.78%
7,641 $847,000
Q1 2019

Apr 26, 2019

SELL
$111.31 - $131.02 $372,665 - $438,654
-3,348 Reduced 30.3%
7,701 $999,000
Q4 2018

Feb 25, 2019

SELL
$105.9 - $118.64 $7,836 - $8,779
-74 Reduced 0.67%
11,049 $1.28 Million
Q3 2018

Nov 08, 2018

BUY
$85.86 - $107.31 $85 - $107
1 Added 0.01%
11,123 $1.19 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $15,064 - $17,289
-199 Reduced 1.76%
11,122 $949,000
Q1 2018

Apr 19, 2018

SELL
$74.21 - $87.6 $1,113 - $1,314
-15 Reduced 0.13%
11,321 $876,000
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $6,227 - $6,679
-76 Reduced 0.67%
11,336 $957,000
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $879,522 - $976,182
11,412
11,412 $976,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $747B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.